CJC-1295 (no DAC)

What is CJC-1295 (no DAC)?

Short-acting GHRH analog without the Drug Affinity Complex. Produces cleaner, more natural GH pulses matching endogenous patterns.

How CJC-1295 (no DAC) works

Same GHRH receptor binding as DAC version but rapidly cleared from circulation.

Benefits & uses

• GH pulse stimulation
• Muscle retention
• Fat loss
• Sleep improvement
• Recovery

Common uses: GH stimulation, body composition, recovery, sleep quality, anti-aging.

CJC-1295 (no DAC) dosage

CJC-1295 (no DAC) half-life

CJC-1295 (no DAC) side effects

Minor injection site reactions, tingling, flushing.

Warnings & monitoring

• Research use only
• Do not use within 1-2h of eating (blunts GH pulse)
• Avoid in active cancer

Preparation & storage

CJC-1295 (no DAC) interactions

• with Insulin

  Caution · moderate

  GH peptides elevate fasting glucose and may interfere with insulin sensitivity; close glucose monitoring required when stacking.

  Timing: Separate dosing windows by 2+ hours

• with Sermorelin

  Caution · mild

  Both are GHRH analogs targeting the same receptor — combining provides no additive GH release and wastes peptide. Pick the longer-acting CJC-1295 for steady elevation.

  Timing: Choose one GHRH analog; do not stack

• with Tesamorelin

  Caution · mild

  Tesamorelin and CJC-1295 are both GHRH analogs. Stacking offers no synergy; redundant receptor competition just doubles cost.

  Timing: Choose one GHRH analog per protocol

• with AOD-9604

  Compatible

  AOD-9604 targets fat metabolism without binding the GH receptor; pairs cleanly with GHRH analogs for body-comp protocols.

  Timing: AOD-9604 morning + CJC nightly

• with GHRP-2

  Compatible

  GHRP-2 produces a strong GH pulse that is amplified by CJC-1295's GHRH effect, though GHRP-2 causes more cortisol and prolactin release than Ipamorelin.

  Timing: Inject together on an empty stomach; allow 2 hours post-meal

• with GHRP-6

  Compatible

  A potent GH-amplifying combination, but GHRP-6's strong ghrelin activity causes significant appetite stimulation — best used during a caloric surplus.

  Timing: Inject together fasted; be aware of strong hunger response within 20 min

• with Hexarelin

  Compatible · low

  Hexarelin (GHRP) + CJC-1295 (GHRH analog) is a potent GH-releasing combination. Hexarelin is more potent than Ipamorelin but less selective. Cortisol and prolactin may also be elevated.

  Timing: Administer together subcutaneously; fasted state preferred for maximum GH pulse

• with Hexarelin

  Compatible

  Hexarelin is a potent GHRP that synergizes with CJC-1295, but desensitizes more rapidly than Ipamorelin — cycle use and avoid daily dosing.

  Timing: Inject together fasted; use 2–3x per week to reduce desensitization

• with Hexarelin

  Compatible

  Hexarelin is a potent GHRP; CJC-1295 sustains the resulting GH pulse. Watch cortisol/prolactin and rotate off hexarelin to preserve sensitivity.

  Timing: Co-inject; cycle 4 weeks on, 2 off due to receptor desensitization

• with Ipamorelin

  Compatible

  The gold-standard GH peptide stack: CJC-1295 extends the GH pulse while Ipamorelin triggers selective GH release with minimal cortisol or prolactin elevation.

  Timing: Inject together 15–30 min before bed or post-workout on an empty stomach

• with MK-677

  Compatible · low

  Both stimulate GH release through different mechanisms (GHRH analog vs. ghrelin mimetic). Additive GH response expected. MK-677 may increase hunger significantly.

  Timing: CJC-1295 pre-bed fasted; MK-677 can be timed similarly for GH pulse synergy

Commonly stacked with